BrainStorm Cell Therapeutics
BCLI
#9918
Rank
S$14.33 M
Marketcap
$2.51
Share price
3.91%
Change (1 day)
-40.17%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$10.91 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total liabilities are S$10.91 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BrainStorm Cell Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31S$15.37 M14.44%
2021-12-31S$13.43 M-35.72%
2020-12-31S$20.89 M-17.37%
2019-12-31S$25.28 M197.98%
2018-12-31S$8.48 M14.47%
2017-12-31S$7.41 M492.88%
2016-12-31S$1.25 M-70.05%
2015-12-31S$4.17 M-2.34%
2014-12-31S$4.27 M69.85%
2013-12-31S$2.51 M78.08%
2012-12-31S$1.41 M-13.09%
2011-12-31S$1.62 M-18.43%
2010-12-31S$1.99 M-43.19%
2009-12-31S$3.5 M-16.84%
2008-12-31S$4.22 M-16.47%
2007-12-31S$5.05 M29.77%
2006-12-31S$3.89 M
2006-03-31S$14.16 M4808.24%
2005-03-31S$0.28 M261.75%
2004-03-31S$0.07 M79.86%
2003-03-31S$0.04 M109.16%
2002-03-31S$0.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$48.81 B 447,004.68%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.95 B 17,840.73%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.46 B 13,310.54%๐Ÿ‡บ๐Ÿ‡ธ USA
S$16.14 B 147,812.65%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.68 B 6,213.86%๐Ÿ‡บ๐Ÿ‡ธ USA